Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Fund Update: New $77.8M $CME stock position opened by Intermede Investment Partners Ltd

None

Intermede Investment Partners Ltd has opened a new $77.8M position in $CME, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CME.

$CME Hedge Fund Activity

We have seen 838 institutional investors add shares of $CME stock to their portfolio, and 732 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$CME Insider Trading Activity

CME Insider Trades

$CME insiders have traded $CME stock on the open market 14 times in the past 6 months. Of those trades, 4 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:

  • TERRENCE A DUFFY (Chairman and CEO) has made 0 purchases and 2 sales selling 25,000 shares for an estimated $6,738,815.
  • SUNIL CUTINHO (Chief Information Officer) has made 0 purchases and 2 sales selling 11,896 shares for an estimated $3,229,444.
  • DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 7,200 shares for an estimated $1,984,798.
  • HAROLD EUGENE JR. FORD sold 1,000 shares for an estimated $263,530
  • JONATHAN L MARCUS (Sr MD General Counsel) has made 0 purchases and 2 sales selling 768 shares for an estimated $200,072.
  • WILLIAM R SHEPARD has made 4 purchases buying 536 shares for an estimated $145,679 and 0 sales.
  • TIMOTHY FRANCIS MCCOURT (Sr MD Global Head Equity & FX) sold 379 shares for an estimated $98,475

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CME Congressional Stock Trading

Members of Congress have traded $CME stock 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CME Analyst Ratings

Wall Street analysts have issued reports on $CME in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • Piper Sandler issued a "Overweight" rating on 11/13/2025
  • Deutsche Bank issued a "Buy" rating on 10/23/2025
  • Morgan Stanley issued a "Overweight" rating on 10/23/2025
  • Citigroup issued a "Buy" rating on 09/25/2025
  • JP Morgan issued a "Underweight" rating on 09/25/2025

To track analyst ratings and price targets for $CME, check out Quiver Quantitative's $CME forecast page.

$CME Price Targets

Multiple analysts have issued price targets for $CME recently. We have seen 11 analysts offer price targets for $CME in the last 6 months, with a median target of $307.0.

Here are some recent targets:

  • Kenneth Worthington from JP Morgan set a target price of $266.0 on 02/05/2026
  • Ashish Sabadra from RBC Capital set a target price of $302.0 on 02/05/2026
  • Benjamin Budish from Barclays set a target price of $312.0 on 02/05/2026
  • Bill Katz from TD Cowen set a target price of $328.0 on 02/05/2026
  • Michael Cyprys from Morgan Stanley set a target price of $340.0 on 02/05/2026
  • Patrick Moley from Piper Sandler set a target price of $313.0 on 11/13/2025
  • Alex Kramm from UBS set a target price of $280.0 on 10/23/2025

Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.

Check out Quiver Quantitative's $CME ticker page for more data.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles